A Peek Into The Markets: US Stock Futures Rise Following Prior Week's Gains

Pre-open movers

U.S. stock futures traded higher in early pre-market trade, after recording gains in the previous week. The Empire State manufacturing index for August is scheduled for release at 8:30 a.m. ET, while the NAHB’s housing market index for August will be released at 10:00 a.m. ET.

The U.S. has the highest number of COVID-19 cases and deaths in the world, with total infections in the country exceeding 5,403,360 with around 170,270 deaths. Brazil confirmed over 3,340,190 cases, while India reported a total of at least 2,647,660 confirmed cases.

Futures for the Dow Jones Industrial Average climbed 107 points to 27,899 while the Standard & Poor’s 500 index futures traded rose 11.75 points to 3,373.25. Futures for the Nasdaq 100 index climbed 67 points to 11,200.75.

Oil prices traded lower as Brent crude futures fell 0.4% to trade at $44.61 per barrel, while US WTI crude futures fell 0.3% to trade at $41.88 a barrel.


A Peek Into Global Markets


European markets were lower today, with the Spanish Ibex Index falling 1.2% and STOXX Europe 600 Index declining 0.5%. The UK's FTSE index was trading lower by 0.5%, while French CAC 40 Index slipped 0.5% and German DAX 30 fell 0.4%.

In Asian markets, Japan’s Nikkei fell 0.83%, Hong Kong’s Hang Seng Index rose 0.89% China’s Shanghai Composite Index rose 2.34% and India’s BSE Sensex rose 0.1%.


Broker Recommendation

Analysts at Credit Suisse upgraded Teladoc Health Inc TDOC from Neutral to Outperform and raised the price target from $225 to $249.

Teladoc Health shares rose 2.4% to $192.00 in pre-market trading.


Breaking News

  • Baxter International Inc BAX disclosed that it has obtained the US FDA emergency use authorization for Regiocit replacement solution used in continuous renal replacement therapy.
  • Sanofi SA SNY announced plans to acquire Principia Biopharma Inc PRNB for $100 per share in cash.
  • Novavax, Inc. NVAX reported that it has initiated Phase 2b efficacy trial of COVID-19 Vaccine in South Africa.
  • CanSino Biologics Inc CASBF has become the first company to secure a patent for its COVID-19 vaccine in China, Reuters reported Sunday.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsA Peek Into The Markets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!